University Of Vermont Medical Center

This study aims to understand how a common breast cancer drug, Verzenio, affects the bacteria living in patients' digestive systems (the gut microbiome). Researchers want to see if changes in these bacteria are connected to digestive side effects like diarrhea that patients often…